المؤلفون: Kenney LB; Department of Pediatrics, Dana-Farber Cancer Institute/Boston Children's Hospital †Department of Pediatric Hematology/Oncology, Massachusetts General Hospital, Boston, MA ‡Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY., Duffey-Lind E, Ebb D, Sklar CA, Grier H, Diller L

المصدر: Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2014 Apr; Vol. 36 (3), pp. 237-40.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505928 Publication Model: Print Cited Medium: Internet ISSN: 1536-3678 (Electronic) Linking ISSN: 10774114 NLM ISO Abbreviation: J Pediatr Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*adverse effects , Bone Neoplasms/*drug therapy , Disorder of Sex Development, 46,XY/*chemically induced , Osteosarcoma/*drug therapy , Spermatogenesis/*drug effects , Testis/*abnormalities, Adolescent ; Adult ; Bone Neoplasms/metabolism ; Cisplatin/administration & dosage ; Cohort Studies ; Doxorubicin/administration & dosage ; Follow-Up Studies ; Humans ; Ifosfamide/administration & dosage ; Luteinizing Hormone/metabolism ; Male ; Methotrexate/administration & dosage ; Osteosarcoma/metabolism ; Prognosis ; Review Literature as Topic ; Testosterone/metabolism ; Young Adult

SCR Disease Name: Leydig Cell Hypoplasia